Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tooth, Impacted 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Hematologic Neoplasms 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma, Cavernous 1Ganglioneuroblastoma 1Fibrolamellar hepatocellular carcinoma 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Renal Cell 1Breast Carcinoma In Situ 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

pembrolizumab 30Nivolumab 30cabozantinib 20Ipilimumab 15Magnetic Resonance Spectroscopy 14belzutifan 13lenvatinib 11Axitinib 9Specimen Handling 8Sunitinib 7durvalumab 5CTLA-4 Antigen 5tislelizumab 4atezolizumab 4Radiosurgery 4Interleukin-2 4Everolimus 4Biopsy 4Bevacizumab 4pazopanib 3avelumab 3aldesleukin 3Immunoglobulin G 3Disulfides 3palbociclib 2fludarabine 2entinostat 2adavosertib 2Surveys and Questionnaires 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Renal Cell × Watchful Waiting × Clear all
NCT03055013 2026-06-03

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

National Cancer Institute (NCI)

Phase 3 Active not recruiting
819 enrolled 12 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡